Isaac E. Ciechanover - Net Worth and Insider Trading

Isaac E. Ciechanover Net Worth

The estimated net worth of Isaac E. Ciechanover is at least $290,781 dollars as of 2024-11-13. Isaac E. Ciechanover is the CEO of Atara Biotherapeutics Inc and owns about 24,917 shares of Atara Biotherapeutics Inc (ATRA) stock worth over $290,781. Details can be seen in Isaac E. Ciechanover's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Isaac E. Ciechanover has not made any transactions after 2019-05-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Isaac E. Ciechanover

Isaac E. Ciechanover Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Isaac E. Ciechanover owns 1 companies in total, including Atara Biotherapeutics Inc (ATRA) .

Click here to see the complete history of Isaac E. Ciechanover’s form 4 insider trades.

Insider Ownership Summary of Isaac E. Ciechanover

Ticker	Comapny	Transaction Date	Type of Owner
ATRA	Atara Biotherapeutics Inc	2019-05-30	director & Chief Executive Officer

Isaac E. Ciechanover Latest Holdings Summary

Isaac E. Ciechanover currently owns a total of 1 stock. Isaac E. Ciechanover owns 24,917 shares of Atara Biotherapeutics Inc (ATRA) as of May 30, 2019, with a value of $290,781.

Latest Holdings of Isaac E. Ciechanover

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ATRA	Atara Biotherapeutics Inc	2019-05-30	24,917	11.67	290,781

Holding Weightings of Isaac E. Ciechanover

Isaac E. Ciechanover Form 4 Trading Tracker

According to the SEC Form 4 filings, Isaac E. Ciechanover has made a total of 0 transactions in Atara Biotherapeutics Inc (ATRA) over the past 5 years. The most-recent trade in Atara Biotherapeutics Inc is the sale of 234 shares on May 30, 2019, which brought Isaac E. Ciechanover around $135,076.

Insider Trading History of Isaac E. Ciechanover

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Isaac E. Ciechanover Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Isaac E. Ciechanover Ownership Network

Ownership Network List of Isaac E. Ciechanover

No Data

Ownership Network Relation of Isaac E. Ciechanover

Isaac E. Ciechanover Owned Company Details

What does Atara Biotherapeutics Inc do?

Who are the key executives at Atara Biotherapeutics Inc?

Isaac E. Ciechanover is the director & Chief Executive Officer of Atara Biotherapeutics Inc. Other key executives at Atara Biotherapeutics Inc include EVP & Global Head RA & Quality Jill Henrich , EVP & Chief Sci. & Tech Officer Anhco Nguyen , and SVP & CFO Eric J Hyllengren .

Atara Biotherapeutics Inc (ATRA) Insider Trades Summary

Over the past 18 months, Isaac E. Ciechanover made no insider transaction in Atara Biotherapeutics Inc (ATRA). Other recent insider transactions involving Atara Biotherapeutics Inc (ATRA) include a net sale of 204,620 shares made by Pascal Touchon , a net sale of 68,971 shares made by Amar Murugan , and a net sale of 64,459 shares made by Eric J Hyllengren .

In summary, during the past 3 months, insiders sold 8,050 shares of Atara Biotherapeutics Inc (ATRA) in total and bought 0 shares, with a net sale of 8,050 shares. During the past 18 months, 27,448 shares of Atara Biotherapeutics Inc (ATRA) were sold and 32,673 shares were bought by its insiders, resulting in a net purchase of 5,225 shares.

Atara Biotherapeutics Inc (ATRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Atara Biotherapeutics Inc Insider Transactions

No Available Data

Isaac E. Ciechanover Mailing Address

Above is the net worth, insider trading, and ownership report for Isaac E. Ciechanover. You might contact Isaac E. Ciechanover via mailing address: C/o Atara Biotherapeutics, Inc., 3260 Bayshore Boulevard, Brisbane Ca 94005.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.